Price T Rowe Associates Inc Krystal Biotech, Inc. Transaction History

Price T Rowe Associates Inc

$869 Billion
Q3 2024

A detailed history of Price T Rowe Associates Inc transactions in Krystal Biotech, Inc. stock. As of the latest transaction made, Price T Rowe Associates Inc holds 438,259 shares of KRYS stock, worth $74.8 Million. This represents 0.01% of its overall portfolio holdings.

Number of Shares

438,259

Previous 600,145 26.97%

Holding current value

$74.8 Million

Previous $110 Million 27.61%

% of portfolio

0.01%

Previous 0.01%

14 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 14, 2024	SELL	$174.7 - $213.66 $28.3 Million - $34.6 Million	-161,886 Reduced 26.97%	438,259 $79.8 Million
Q2 2024 Aug 14, 2024	SELL	$153.12 - $183.64 $8.95 Million - $10.7 Million	-58,473 Reduced 8.88%	600,145 $110 Million
Q1 2024 May 15, 2024	BUY	$108.01 - $179.35 $25 Million - $41.5 Million	231,255 Added 54.11%	658,618 $117 Million
Q4 2023 Feb 14, 2024	BUY	$96.0 - $128.29 $16.4 Million - $22 Million	171,157 Added 66.8%	427,363 $53 Million
Q3 2023 Nov 14, 2023	SELL	$108.51 - $130.22 $7.46 Million - $8.95 Million	-68,741 Reduced 21.15%	256,206 $29.7 Million
Q2 2023 Aug 14, 2023	BUY	$78.48 - $130.32 $24.7 Million - $41 Million	314,337 Added 2962.65%	324,947 $38.2 Million
Q1 2023 May 15, 2023	BUY	$72.39 - $84.27 $49,804 - $57,977	688 Added 6.93%	10,610 $850,000
Q4 2022 Feb 14, 2023	SELL	$63.14 - $79.9 $17,174 - $21,732	-272 Reduced 2.67%	9,922 $786,000
Q3 2022 Nov 14, 2022	BUY	$64.85 - $82.4 $208,687 - $265,163	3,218 Added 46.13%	10,194 $711,000
Q2 2022 Aug 15, 2022	SELL	$48.93 - $73.47 $122,178 - $183,454	-2,497 Reduced 26.36%	6,976 $458,000
Q1 2022 May 16, 2022	BUY	$51.99 - $72.11 $71,122 - $98,646	1,368 Added 16.88%	9,473 $630,000
Q4 2021 Feb 14, 2022	BUY	$39.81 - $88.24 $154,701 - $342,900	3,886 Added 92.11%	8,105 $567,000
Q2 2021 Aug 16, 2021	BUY	$62.14 - $81.82 $31,070 - $40,910	500 Added 13.44%	4,219 $287,000
Q1 2021 May 17, 2021	BUY	$59.42 - $85.46 $220,982 - $317,825	3,719 New	3,719 $287,000

Others Institutions Holding KRYS

# of Institutions

310

Shares Held

24.4M

Call Options Held

483K

Put Options Held

364K

View Full List

About Krystal Biotech, Inc.

Ticker KRYS
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 25,664,300
Market Cap $4.38B
Description
Krystal Biotech, Inc., a clinical stage biotechnology company, engages in the field of redosable gene therapy to treat serious rare diseases in the United States. Its lead product candidate is beremagene geperpavec (B-VEC), which is in Phase III clinical study to treat dystrophic epidermolysis bullosa. The company is also involved in developing ...

More about KRYS

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Price T Rowe Associates Inc , based on Form 13F filings with the SEC.

News

Stay updated on Price T Rowe Associates Inc with notifications on news.

Account

Price T Rowe Associates Inc Krystal Biotech, Inc. Transaction History